Meet Paul Rennert, CEO, President & CSO of Aleta Biotherapeutics at #Sachs_ELSF

More info @ https://t.co/hgPC4hxz57#Sachs_ELSF #SSLSW #lifesciences #partnering #bd #licensing #health #investment #startup #healthcare #innovation #biotech #business #invest #medicine pic.twitter.com/LAtw8WfEld

— Sachs Associates (@SachsAssociates) February 24, 2023